Page 528 - ACCCN's Critical Care Nursing

Support of Renal Function 505

90. Naka T, Egi M, Bellomo R, Cole L, French C et al. Commercial low citrate results from The Beginning and Ending Supportive Therapy for the Kidney
anticoagulation haemofiltration in high risk patients with frequent filter (BEST Kidney) Study. Critical Care Forum, Available at http://ccforum.com/
clotting. Anaesthes Intens Care 2005; 33(5): 601–8. content/14/2/R46; 2010.
91. Mehta R, McDonald B, Aguilar M, Ward D. Regional citrate anticoagulation 100. Cruz D, Bobek I, Lentini P, Soni S, Chionh CY, Ronco C. Machines for
in continuous arteriovenous hemodialysis in critically ill patients. Kidney Int Continuous Renal Replacement Therapy. Seminars in Dialysis 2009; 22(2):
1990; 38, 976–81. 123–32.
92. Davies H, Morgan D, Leslie GD. A Regional Citrate Anticoagulation Protocol 101. Baldwin I. Training management and credentialling for CRRT in critical care.
for Pre-dilutional CVVHDf: The ‘Alabama Concept’. Australian Critical Care Am J Kidney Dis 1997; 30(5): S112–16.
2008; 21(3): 154–6. 102. Craig M. Continuous venous to venous hemofiltration – implementing and
93. Tolwani AJ, Wille K. Anticoagulation for continuous renal replacement maintaining a program: examples and alternatives. Crit Care Nurs Clin N Am
therapy. Seminars in Dialysis 2009; 22(2): 141–5. 1998; 10: 219–33.
94. Heering P, Ivens K, Thumer O, Brause M, Grabensee B. Acid–base balance 103. Schetz M, Leblanc M, Murray P. The acute dialysis quality initiative – part
and substitution fluid during continuous hemofiltration. Kidney Int 1999; VII: fluid composition and management in CRRT. Adv Renal Replace Ther
56(Suppl 72): s37–40. 2002; 9(4): 282–9.
95. Barenbrock M, Hausberg M, Matzkies F, de la Motte S, Schaefer RM. Effects 104. Mehta R. Fluid management in continuous renal replacement therapy. Semin
of bicarbonate and lactate buffered replacement fluids on cardiovascular Dial 1996; 9: 140–44.
outcome in CVVH patients. Kidney Int 2000; 58(4): 1751–7. 105. Ronco C. Machines used for continuous renal replacement therapy. In:
96. Kierdorf HP, Leue C, Arns S. Lactate or bicarbonate buffered solutions in Kellum J, Bellomo R, Ronco C, eds. Continuous renal replacement therapy. New
continuous extracorporeal renal replacement therapies. Kidney Int 1999; York: Oxford University Press; 2010.
56(Suppl 72): s32–6. 106. Baldwin I, Fealy N. Clinical nursing for the application of renal replacement
97. Thomas AN, Guy JM, Kishen R, Geraghty IF, Bowles BJM, Vadgama P. Com- therapies in the Intensive Care Unit. Seminars in Dialysis 2009: 22(2):
parison of lactate and bicarbonate buffered haemofiltration fluids: use in 189–93.
critically ill patients. Nephrol Dial Transplant 1997; 12(6): 1212–17. 107. Phipps W, Monahan F, Sands J et al. Medical-surgical nursing, 7th edn.
98. Bellomo R, Baldwin I, Fealy N. Prolonged intermittent renal replacement St Louis: Mosby; 2003.
therapy in the intensive care unit. Crit Care Resusc 2002; 4: 281–90. 108. Mader S. Inquiry into Life, 11th edn. New York: McGraw-Hill; 2006.
99. Nattachai S, Lawsin L, Uchino S, Bellomo R, Kellum JA, BEST kidney Inves-
tigators. Cost of acute renal replacement therapy in the intensive care unit: